Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Saved in:
Bibliographic Details
Title: Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.
Authors: Prasert K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Nakphook S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Kittiwatanachod J; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Sornwong K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Naosri S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Ongarj P; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Techatanawat I; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Narakorn P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Surichan S; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Flores J; PATH, Seattle, WA 98103, USA., Mercer LD; PATH, Seattle, WA 98103, USA., Polyak CS; PATH, Seattle, WA 98103, USA., Innis BL; PATH, Seattle, WA 98103, USA., Raghunandan R; PATH, Seattle, WA 98103, USA., Pittayawonganon C; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Iamsirithaworn S; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Sirilak S; Health Systems Research Institute, Nonthaburi 11000, Thailand., Wirachwong P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Praphasiri P; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.
Source: Vaccines [Vaccines (Basel)] 2026 May 28; Vol. 14 (6). Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42347602
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Prasert+K%22">Prasert K</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.<br /><searchLink fieldCode="AU" term="%22Nakphook+S%22">Nakphook S</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Kittiwatanachod+J%22">Kittiwatanachod J</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.<br /><searchLink fieldCode="AU" term="%22Sornwong+K%22">Sornwong K</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Naosri+S%22">Naosri S</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Ongarj+P%22">Ongarj P</searchLink>; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Techatanawat+I%22">Techatanawat I</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Narakorn+P%22">Narakorn P</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Surichan+S%22">Surichan S</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Flores+J%22">Flores J</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Polyak+CS%22">Polyak CS</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Innis+BL%22">Innis BL</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Raghunandan+R%22">Raghunandan R</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Pittayawonganon+C%22">Pittayawonganon C</searchLink>; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Iamsirithaworn+S%22">Iamsirithaworn S</searchLink>; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Sirilak+S%22">Sirilak S</searchLink>; Health Systems Research Institute, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Wirachwong+P%22">Wirachwong P</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Praphasiri+P%22">Praphasiri P</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2026 May 28; Vol. 14 (6). <i>Date of Electronic Publication: </i>2026 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42347602
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines14060481
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Prasert K
      – PersonEntity:
          Name:
            NameFull: Nakphook S
      – PersonEntity:
          Name:
            NameFull: Kittiwatanachod J
      – PersonEntity:
          Name:
            NameFull: Sornwong K
      – PersonEntity:
          Name:
            NameFull: Naosri S
      – PersonEntity:
          Name:
            NameFull: Ongarj P
      – PersonEntity:
          Name:
            NameFull: Techatanawat I
      – PersonEntity:
          Name:
            NameFull: Narakorn P
      – PersonEntity:
          Name:
            NameFull: Surichan S
      – PersonEntity:
          Name:
            NameFull: Flores J
      – PersonEntity:
          Name:
            NameFull: Mercer LD
      – PersonEntity:
          Name:
            NameFull: Polyak CS
      – PersonEntity:
          Name:
            NameFull: Innis BL
      – PersonEntity:
          Name:
            NameFull: Raghunandan R
      – PersonEntity:
          Name:
            NameFull: Pittayawonganon C
      – PersonEntity:
          Name:
            NameFull: Iamsirithaworn S
      – PersonEntity:
          Name:
            NameFull: Sirilak S
      – PersonEntity:
          Name:
            NameFull: Wirachwong P
      – PersonEntity:
          Name:
            NameFull: Praphasiri P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1